Consumer safety drive triggers harsh action on Indian nutraceuticals
New Delhi, 16 November – The Food Safety and Standards Authority of India has taken firm action against six nutraceutical producers after a series of inspections uncovered multiple safety and labeling breaches. Licences of the identified firms have been suspended pending further review.
The six firms – Aaren Herbs, Aquabliss Lifesciences, Raskam Healthcare, Supercure Biotech, Embico Ayurvedic Healthcare and Vedant Remedies – were each found to fall short of mandatory standards. Aaren Herbs' LycoVey Syrup was shown to contain excessive amounts of several vitamins and minerals, surpassing the recommended dietary allowance per serving. Its Maxford Pain Relief product also claimed knee-pain benefits not supported by evidence and displayed misleading marketing images.
Aquabliss Lifesciences stored raw ingredients past their expiry date and did not maintain acceptable hygiene levels in its plant. Raskam Healthcare incorporated shilajit into formulations without regulatory approval and lacked proper record-keeping. Supercure Biotech's Gemcolin 9G Softgel Capsule exceeded the allowed biotin limit, while another softgel marketed as vitamin E actually contained wheat germ oil.
Embico Ayurvedic Healthcare was found using expired substances in its nutraceutical range and showed inadequate sanitation. Vedant Remedies used expired flavoring agents and failed to meet standards for cleanliness, infrastructure, and testing facilities.
FSSAI reiterated that consumer health is paramount as the nutraceutical market expands rapidly. The agency affirmed that regular monitoring, strict enforcement and transparent manufacturing practices will remain central to its mission.
